¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Factitious disease by proxy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • neoplastic disease
    ½Å»ý¹°º´, Á¾¾çº´
  • nervous disease
    ½Å°æ°èÁúȯ, ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • occupational disease
    Á÷¾÷º´
  • organic disease
    ±âÁúº´
  • Osgood-Schlatter disease
    ¿À½º±Â-½¶¶óÅͺ´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • Owren¡¯s disease
    ¿Àºê·»º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pericardial disease
    ½ÉÀ帷º´
  • periodontal disease
    Ä¡ÁÖº´, Ä¡±Ù¸·º´
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°»çº´
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸ÓÁõ
  • polycystic kidney disease
    ¹µÁÖ¸Ó´ÏÄáÆÏº´, ´Ù³¶ÄáÆÏº´
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • professional disease
    Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulmonary disease
    Æóº´
  • pulseless disease
    ¹«¸Æ¹Úº´, ¹«¸Æº´
  • pyramidal disease
    ÇǶó¹Ô½Å°æ·Îº´, Ãßü½Å°æ·Îº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë ¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ
  • granulomatous disease of childhood
    ¼Ò¾ÆÀ°¾ÆÁ¾¼º Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • disease
    º´(º´), Áúº´(Áúº´), Áúȯ(Áúȯ).
  • disease
    Áúº´(Ü»), Áúȯ(òðü´)
  • disease
    º´, Áúº´, Áúȯ
  • disease
    º´(Ü»), Áúº´(òðÜ»), Áúȯ(òðü´).
  • disease
    º´(ËÓ), Áúº´(̤ËÓ), Áúȯ(̷̤).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(Ü»êÂô÷ÜÁêóíº).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(ËÓËô̧ËÓËôËö).
  • disease control
    Áúº´°ü¸®.
  • disease detection
    Áúº´¹ß°ß.
  • disease entity
    Áúº´´ÜÀ§(òðܻӤêÈ).
  • disease entity
    Áúº´´ÜÀ§(̤ËÓËÀËô).
  • disease free interval
    ¹«º´±â°£
  • disease free survival
    ¹«º´»ýÁ¸
  • disease potential
    Áúº´ÀáÀç·Â.
  • disease prevention
    Áúº´¿¹¹æ(¡­çãÛÁ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
SMCD senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease
URD unspecified respiratory disease; upper respiratory disease
VD vapor density; vascular disease; vasodilation, vasodilator; venereal disease; venous dilatation; ven...
VHD valvular heart disease; viral hematodepressive disease
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
CLD Chronic liver disease
CNSLD Chronic non-specific lung disease
CRD Chronic renal disease
CWD Chronic wasting disease
CAD Cold agglutinin disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • restrictive pulmonary disease
    ±¸¼Ó¼º Æó Áúȯ
  • retimal degenerative disease
    ¸Á¸· ÅðÇ༺ Áúȯ
    ±¹¼Ò ¸ð¼¼ Ç÷°ü °æÈ­¿Í ±¸¸Û Çü¼º°ú ÇÔ²² ¸Á¸· ÃÊÀÚü Á¢Ã˸éÀ» ħ¹üÇϰųª ¶Ç´Â ¸Á¸· ÃÊÀÚü À¯Âø°ú ÃÊÀÚü ¾×È­°¡ ¸Á¸· °ßÀÎ, ¸Á¸·ÀÇ ¸»±Á ¸ð¾ç ÆÄ¿­, ±×¸®°í ¹Ú¸®¸¦ ÀÏÀ¸Å°´Â ºÐ¸®µÈ ºÎÀ§·Î¼­ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
  • rheumatic disease
    ·ù¸¶Æ¼¼º Áúȯ, ·ù¸¶Æ¼½º¼º Áúȯ
  • rheumatic valvular disease
    ·ù¸¶Æ¼½º¼º ÆÇ¸· Áúȯ
  • rheumatoid disease
    ·ù¸¶Æ¼½º¾ç Áúȯ
    Ư¡À¸·Î¼­ Ȱ¸·¿°. °üÀý ÆÄ±«, °üÀý º¯Çü µîÀÇ °üÀýħ½ÀÀ» ÁÖ·Î ÇÏ´Â Àü½Å¼º Áúȯ.
  • Riga-Fede disease
    ¸®°¡-Æäµ¥º´
    ¼Ò¾ÆÀÇ ¼³¼Ò´ëÀÇ À°¾ÆÁ¾À¸·Î ÇÏ¾Ç ÁßÀýÄ¡¿¡ ÀÇÇÑ ¸¶Âû ÈÄ¿¡ »ý±ä´Ù.
  • saccharine disease
    »çÄ«¸° º´
    ½ÄÀ̼º ¼¶À¯¿Í ´Ü¹éÁúÀ» Á¦°ÅÇϰí Á¤Á¦ÇÑ ÇÔ¼öź¼Ò ½Ä»ç¸¦ °úµµÇÏ°Ô ¼·ÃëÇÏ¿© »ý±â´Â Áúº´¿¡ ´ëÇÏ¿© Á¦Ã¢µÈ ¿ë¾îÀÌ´Ù. À̰Ϳ¡´Â ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, º¯ºñ, ºñ¸¸Áõ ¹× ¼ÒÈ­¼º ±Ë¾ç µîÀÌ Æ÷ÇԵȴÙ.
  • salivary gland disease
    Ÿ¾×¼± Áúȯ
  • Saunders' disease
    »ç¿î´õÁî º´
    Á¥¸ÔÀÌ¿¡°Ô °ú·®ÀÇ Åº¼öÈ­¹° À½½ÄÀ» ÁÖ¾úÀ» ¶§ ÀϾ´Â ¼ÒÈ­ Àå¾Ö¿¡¼­ º¼ ¼ö ÀÖ´Â À§ÇèÇÑ Áõ»ó. ±¸Åä, ³ú Áõ»ó, ¼øÈ¯ Àå¾Ö°¡ Ư¡ÀÌ´Ù.
  • Schamberg's disease ¸¸¼º, ¹«Áõ»ó¼º ÇǺΠÁúȯÀ¸·Î »çÃá±â¿Í Àå³â±âÀÇ ³²ÀÚ¿¡°Ô ¹ß»ýÇÑ´Ù. ¾Õ Á¤°­ÀÌ, ¹ß¸ñ, ¹ß, ¹ß°¡¶ô µî¿¡ ±¹ÇÑÇÏ¿© ³ªÅ¸³ª´Â µî»ö ¶Ç´Â ´ãȲ °¥»öÀÇ °¡ÀåÀÚ¸®¿¡ Àû»öÁ¡À» °¡Áø ¹Ý»ó ¹ßÁøÀ» Ư¡À¸·Î ÇÑ´Ù.

    Schanz's syndrome

    ¼¢Áî ÁõÈıº
    ÇǷΰ¨, ôÃß µ¹±âÀÇ ¾ÐÅë, º¹¿ÍÀ§¿¡¼­ÀÇ µ¿Åë, ôÃß ¸¸°î µî, ôÃßÀÇ ¼è¾àÀ» ³ªÅ¸³»´Â ÀÏ·ÃÀÇ ÁõÈÄ.
  • Schilder's disease
    ½¯´õº´
    1. 1912³â¿¡ ±âÀçÇÑ ¼Ò¾Æ ¹× ÀþÀºÀÌ¿¡°Ô ÀϾ´Â ¿øÀÎ ºÒ¸íÀÇ µå¹® ÁúȯÀ¸·Î¼­, ÁÖ·Î ´ë³ú ¹Ý±¸¸¦ ħ¹üÇϸç, Á¶±â¿¡ Àå´Ô, ±Í¸Ó°Å¸®, °¨°¢Àå¿¡ µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù. 2. ¹éÁú³úÁõÀÇ ¾Æ±Þ¼º ¶Ç´Â ¸¸¼ºÇüÀ¸·Î ¼Ò¾Æ ¹× û³â¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÁõ»óÀ¸·Î´Â ½Ç¸í, ³­Ã», ¾çÃø¼º °æ·Ã, ÁøÇ༺ Á¤½ÅȲÆó µîÀÌ ³ªÅ¸³­´Ù. ´ë³ú ¹éÁúÀÇ ±¤¹üÇÑ ÆÄ±«°¡ ÀÖ°í, °øµ¿ÀÌ Çü¼ºµÈ´Ù. º¸Åë »ê¹ßÀûÀ¸·Î ¹ß»ýÇϳª °¡Á·¼ºÀÇ º´ÇüÀ¸·Îµµ º¸°íµÇ¾î ÀÖ´Ù.
  • Schmorl's disease
    ½¬¸ð¸¦ º´
    1. ÀÎÁ¢ÇÑ º¹Ã¼ºÎ¿¡ÀÇ ¼öÇÙ Å»Ãâ.
  • Scholz's disease
    ¼ñÃ÷ º´
    ¹éÁú ³úÁõÀÇ °¡Á· ¼ºÇüÀ¸·Î ¹Ý¼º ¿­¼º À¯Àü. 8¼¼ °æ¿¡ ½ÃÀÛÇÏ¿© ³ú¹éÁúÀÇ Å»¼öÈ­, °¨°¢¼º ½Ç¾îÁõ, ÇÇÁú¼º ½Ç¸í, ³­Ã», Çã¾à, »çÁöÀÇ °æ·Ã, ¿ÏÀü ¸¶ºñ, Ä¡¸Å°¡ Ư¡ÀÌ´Ù.
  • seasonal disease
    °èÀýº´
    °èÀý¿¡ µû¶ó ¹ß»ýÇÏ´Â º´ÀÇ ÃÑĪ. °èÀýÀÇ º¯È­°¡ º´À» ÀÏÀ¸Å²´Ù´Â °ÍÀ» óÀ½ ±â·ÏÇÑ »ç¶÷Àº È÷Æ÷Å©¶óÅ×½º¿´´Âµ¥, À̸¦ ±Ù´ë ÀÇÇÐÀûÀÎ ¹æ¹ýÀ¸·Î ¿¬±¸ÇÑ »ç¶÷Àº µ¶ÀÏÀÇ µ¥ ·ç´õ¿´´Ù. ±×´Â ±â´Ü ±³Ã¼ ¶§ÀÇ Àü¼± Åë°ú¿Í °¢Á¾ Áúº´°úÀÇ °ü·ÃÀ» Åë°èÇÐÀûÀ¸·Î Á¶»çÇÏ¿´À¸¸ç, ƯÈ÷ ºÏ¹Ý±¸ÀÇ °èÀý°ú °ü°è°¡ ±íÀº Áúº´ÀÇ ¿¬°£ºÐÆ÷Ç¥´Â °èÀýº´ ͏°´õÀÇ ½ÃÃʷμ­ À¯¸íÇÏ´Ù. ¾î¶² º´À» °èÀýº´À¸·Î Ãë±ÞÇϱâ À§Çؼ­´Â, ±× º´ÀÇ À¯¹ßÀÎÀÚ ¶Ç´Â ±× º´À» Àü¿°½ÃŰ´Â À§»ý °ïÃæ µîÀÌ °èÀýÀûÀ¸·Î º¯µ¿Çϰí ÀÖ´Ù´Â Á¡, ¶Ç´Â Àΰ£ ÀÚü°¡ ±× º´¿¡ °É¸®±â ½¬¿î »óŰ¡ °èÀý¿¡ ÀÇÇØ¼­ Á¿ìµÈ´Ù´Â Á¡ µîÀÌ ¾î¶»°Ô ¼­·Î ¾ôÇô ÀÖ´ÂÁö Á¶»çÇÒ Çʿ䰡 ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì, ¾î¸°ÀÌÀÇ ¼ÒÈ­±â º´À̳ª ´Üµ¶ µîÀÇ ÇǺΠÁúȯÀº ¿©¸§¿¡ ¸¹°í, °Ü¿ï¿¡¼­ º½¿¡ À̸£·¯ Â÷°í ¸Þ¸¶¸¥ ±âÈÄÀÏ ¶§¿¡´Â °¨±â, Æó·Å, ±Þ¼º ±â°üÁö¿° µîÀÌ ¸¹´Ù.
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
Marie-Strumpell disease <rheumatology> A polyarthritis involving the spine, which is characterised by progressive, painful stiffening of the joints and ligaments. It almost exclusively affects young men.
Interestingly the disease seems to be associated with HLA B27, those with this histocompatability antigen are 300 times more likely to get the disease, 90% of sufferers have HLA B27
(18 Nov 1997)
Marion's disease A congenital obstruction of the posterior urethra.
(05 Mar 2000)
Recklinghausen's disease of bone Rarefying osteitis with fibrous degeneration and formation of cysts, and with the presence of fibrous nodules on the affected bones. It is due to marked osteoclastic activity secondary to hyperfunction of the parathyroid glands.
(12 Dec 1998)
Recklinghausen's disease type I type 2 neurofibromatosis
Gerhardt-Mitchell disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
Gerhardt's disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
vertebral-basilar artery disease <cardiology> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch.
These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
Gerlier's disease A paroxysmal attack of severe vertigo, not accompanied by deafness or tinnitus, which affects young to middle-aged adults, often following a non-specific upper respiratory infection; due to unilateral vestibular dysfunction.
Synonym: endemic paralytic vertigo, epidemic vertigo, Gerlier's disease, kubisagari, kubisagaru, paralyzing vertigo.
(05 Mar 2000)
Martin's disease A periosteoarthritis of the foot from excessive walking.
(05 Mar 2000)
Carrington's disease <radiology> Idiopathic, associated with allergies and desensitization, variant of Loeffler pneumonia, treatment: corticosteroids Findings: reverse pulmonary oedema pattern (= Loeffler's), areas of consolidation persists (days to weeks) see: eosinophilic lung disease
(12 Dec 1998)
Carrion's disease A generalised, acute, febrile, endemic, and systemic form of bartonellosis; marked by high fever, rheumatic pains, progressive, severe anaemia, and albuminuria.
Synonym: Carrion's disease.
(05 Mar 2000)
gestational trophoblastic disease (choriocarcinoma, molar pregnancy) a type of cancer associated with pregnancy in which a grape-like mole develops in the womb instead of a foetus.
(16 Dec 1997)
parkinson disease Progressive, degenerative disease of unknown aetiology characterised by rhythmic tremor of the limbs, stooped posture, slowness of voluntary movements, and masklike facial expression. Pathologically there is nerve cell loss in the melanin-containing cells in the brainstem and a corresponding reduction in dopamine levels in the corpus striatum. Lewy bodies are present in the substantia nigra and locus coeruleus.
(12 Dec 1998)
parkinson disease, postencephalitic A form of parkinson disease due to degeneration of the corpus striatum or substantia nigra, frequently occurring as a sequel of lethargic encephalitis. The early age of onset, the rapid progression of symptoms and signs of stabilization, and the presence of a variety of other neurological disorders (sociopathic behaviour, tics, spasms, oculogyric crises and other restricted motor disorders, breathing arrhythmias, hyperphagia, and bizarre movements, postures, and gaits) distinguish this disease from the one described by parkinson.
(12 Dec 1998)
parkinson disease, symptomatic Symptoms of parkinson disease induced by drugs, or following cerebral arteriosclerosis, brain tumour, or other central nervous system disorders except encephalitis, which is parkinson disease, postencephalitic.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á